RU2237672C2 - Новые производные эритромицина, способ их получения и применение в качестве медикаментов - Google Patents

Новые производные эритромицина, способ их получения и применение в качестве медикаментов Download PDF

Info

Publication number
RU2237672C2
RU2237672C2 RU99125547A RU99125547A RU2237672C2 RU 2237672 C2 RU2237672 C2 RU 2237672C2 RU 99125547 A RU99125547 A RU 99125547A RU 99125547 A RU99125547 A RU 99125547A RU 2237672 C2 RU2237672 C2 RU 2237672C2
Authority
RU
Russia
Prior art keywords
formula
erythromycin
derivatives
ppm
methyl
Prior art date
Application number
RU99125547A
Other languages
English (en)
Russian (ru)
Other versions
RU99125547A (ru
Inventor
Алексис ДЕНИ (FR)
Алексис Дени
Original Assignee
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст Марион Руссель filed Critical Хехст Марион Руссель
Publication of RU99125547A publication Critical patent/RU99125547A/ru
Application granted granted Critical
Publication of RU2237672C2 publication Critical patent/RU2237672C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
RU99125547A 1998-11-24 1999-11-23 Новые производные эритромицина, способ их получения и применение в качестве медикаментов RU2237672C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814782 1998-11-24
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (2)

Publication Number Publication Date
RU99125547A RU99125547A (ru) 2001-09-10
RU2237672C2 true RU2237672C2 (ru) 2004-10-10

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99125547A RU2237672C2 (ru) 1998-11-24 1999-11-23 Новые производные эритромицина, способ их получения и применение в качестве медикаментов

Country Status (24)

Country Link
US (2) US6440941B1 (https=)
EP (1) EP1004592B1 (https=)
JP (1) JP2000159790A (https=)
KR (1) KR100587445B1 (https=)
CN (1) CN1165546C (https=)
AR (1) AR021388A1 (https=)
AT (1) ATE245160T1 (https=)
AU (1) AU772171B2 (https=)
BR (1) BR9905735A (https=)
CA (1) CA2290136C (https=)
DE (1) DE69909577T2 (https=)
DK (1) DK1004592T3 (https=)
ES (1) ES2198867T3 (https=)
FR (1) FR2786188B1 (https=)
HU (1) HUP9904392A3 (https=)
IL (1) IL133101A (https=)
MX (1) MXPA99010813A (https=)
NO (1) NO314729B1 (https=)
PL (1) PL336736A1 (https=)
PT (1) PT1004592E (https=)
RU (1) RU2237672C2 (https=)
TR (1) TR199902888A3 (https=)
TW (1) TWI247747B (https=)
ZA (1) ZA997176B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
CA2359708C (en) 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
HUP0201516A3 (en) 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
WO2009137787A1 (en) * 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0596802A1 (fr) * 1992-11-05 1994-05-11 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, leur application comme médicaments
GB2288174A (en) * 1994-04-08 1995-10-11 Roussel Uclaf Erythromycin derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as medicaments
RU2114859C1 (ru) * 1992-11-05 1998-07-10 Руссель Юклаф Производные эритромицина, фармацевтическая композиция, способ получения производных эритромицина

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0596802A1 (fr) * 1992-11-05 1994-05-11 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, leur application comme médicaments
RU2114859C1 (ru) * 1992-11-05 1998-07-10 Руссель Юклаф Производные эритромицина, фармацевтическая композиция, способ получения производных эритромицина
GB2288174A (en) * 1994-04-08 1995-10-11 Roussel Uclaf Erythromycin derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ferroni R. et al. Arzneimittel-Forshung. 1990, 40(6), 705-9, abstract: Chemical Abstracts, 113: 171942. Асратян Г.В. и др. Журнал прикладной химии. 1986, т. LIX, № 6, с. 1296-1300. *

Also Published As

Publication number Publication date
CA2290136C (fr) 2010-07-20
FR2786188B1 (fr) 2002-10-31
CN1263101A (zh) 2000-08-16
KR20000057017A (ko) 2000-09-15
CA2290136A1 (fr) 2000-05-24
NO995745L (no) 2000-05-25
HU9904392D0 (en) 2000-01-28
ATE245160T1 (de) 2003-08-15
PL336736A1 (en) 2000-06-05
NO314729B1 (no) 2003-05-12
IL133101A0 (en) 2001-03-19
MXPA99010813A (es) 2005-09-08
DE69909577T2 (de) 2004-06-03
TR199902888A2 (xx) 2000-06-21
EP1004592B1 (fr) 2003-07-16
US20030050254A1 (en) 2003-03-13
AU772171B2 (en) 2004-04-08
TWI247747B (en) 2006-01-21
AU5952299A (en) 2000-05-25
FR2786188A1 (fr) 2000-05-26
EP1004592A1 (fr) 2000-05-31
US6664398B2 (en) 2003-12-16
US6440941B1 (en) 2002-08-27
HUP9904392A3 (en) 2001-08-28
HUP9904392A2 (hu) 2000-05-28
AR021388A1 (es) 2002-07-17
JP2000159790A (ja) 2000-06-13
BR9905735A (pt) 2000-08-08
DK1004592T3 (da) 2003-10-27
DE69909577D1 (de) 2003-08-21
KR100587445B1 (ko) 2006-06-08
NO995745D0 (no) 1999-11-23
TR199902888A3 (tr) 2000-06-21
IL133101A (en) 2007-02-11
PT1004592E (pt) 2003-12-31
CN1165546C (zh) 2004-09-08
ZA997176B (en) 2000-11-20
ES2198867T3 (es) 2004-02-01

Similar Documents

Publication Publication Date Title
RU2237672C2 (ru) Новые производные эритромицина, способ их получения и применение в качестве медикаментов
JP2992540B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用
JP3140703B2 (ja) 新規なエリスロマイシン、それらの製造法及び薬剤としての用途
JP5222348B2 (ja) 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
JP3334980B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
JP4102440B2 (ja) 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用
KR100371473B1 (ko) 신규한에리스로마이신유도체,그의제조방법및의약으로서의용도
KR100567695B1 (ko) 에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도
JP4573925B2 (ja) 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
JP4267700B2 (ja) エリスロマイシンの新規な誘導体、それらの製造法及びそれらの薬剤としての使用
JP4363666B2 (ja) 新規なエリスロマイシン誘導体、それらの製造方法及びそれらの医薬としての利用
JP4864184B2 (ja) ５−デスオサミニルエリスロノリドａの新規の２−ハロゲン化誘導体、それらの製造方法及び薬剤としてのそれらの使用
JP4583601B2 (ja) 新規の６−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
JP2001507011A (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
CZ417699A3 (cs) Nové deriváty erythromycinu, způsob jejich přípravy a jejich použití jako léčiv

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20051124